References
- Aspelin P, Aubry P, Fransson S-G, Strasser R, Willenbrock E, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491–9.
- Davidson C, Stacul F, McCullough PA, Tumlin J, Adam, A, Lameire N, . Contrast medium use. Am J Cardiol 2006;98:42K–58K.
- Rudnick MR, Kesselheim A, Goldfarb S. Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med 2006;73:75–87.
- Levorstad K, Vatne K, Brodahl U, Laake B, Simonsen S, Aakhus T. Safety of the nonionic contrast medium Omnipaque in coronary angiography. Cardiovasc Interv Radiol 1989;12:98–100.
- Missri J, Jeresaty RM. Ventricular fibrillation during coronary angiography: reduced incidence with nonionic contrast media. Cathet Cardiovasc Diagn 1990;19:4–7.
- Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, . ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999;33:1756–824.
- Christiansen C. X-ray contrast media-an overview. Toxicology 2005;209:185–7.
- Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006;12:210–15.
- Thaning M, European Patent Application WO2009008734 A2.
- Eersels JLH, Travis, MJ, Hersheid JDM. Manufacturing I-123-labelled radiopharmaceuticals. Pitfalls and solutions. Journal of Labelled Compounds and Radiopharmaceuticals 2005;48:241–57.
- Jacobsen PB, Blindheim L, Skotland T. Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding, Acta Radiol 1995;36:S61–S66.
- Eivindvik K, Sjogren CE. Physicochemical properties of iodixanol. Acta Radiol 1995;36:S32–S38.
- Gerber BO, Pichler WJ. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. AAPS J 2006;8:E160–5.
- Fernandez-Rodriguez S, Edwards DH, Newton B, Griffith TM. Attenuated store-operated Ca2+ entry underpins the dual inhibition of nitric oxide and EDHF-type relaxations by iodinated contrast media. Cardiovasc Res 2009;84: 470–8.
- Sontum PC, Christiansen C, Kasparkova V, Skotland T. Evidence against molecular aggregates in concentrated solutions of X-ray contrast media. International Journal of Pharmaceutics 1998;169:203–12.
- Sontum PC, Skotland T. Absence of large molecular aggregates in X-ray contrast media. Eur Radiol 2007;17: 1377–9.
- Heglund IF, Michelet ÅA, Blazak WF, Furuhama K, Holtz E. Preclinical pharmacokinetics and general toxicology of iodixanol. Acta Radiol 1995;36:S69–S82.
- Sovak M, Terry R, Abramjuk C, Faberova V, Fiserova M, Lazniek M, . Iosimenol. A low-viscosity nonionic dimer. Preclinical physicochemistry, pharmacology and pharmacokinetics. Invest Radiol 2004;39:171–81.